159 related articles for article (PubMed ID: 33968653)
21. Editorial by Bendu K. Konneh, John T. Lafin and Aditya Bagrodia on pp. 341-342 of this issue: MicroRNA-371a-3p as a blood-based biomarker in testis cancer.
Ahmadi H; Jang TL; Daneshmand S; Ghodoussipour S
Asian J Urol; 2021 Oct; 8(4):400-406. PubMed ID: 34765447
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in serum and cerebrospinal fluid identify patients with intracranial germ cell tumors.
Schönberger S; Mohseni MM; Ellinger J; Tran GVQ; Becker M; Claviez A; Classen CF; Hermes B; Driever PH; Jorch N; Lauten M; Mehlitz M; Schäfer N; Scheer-Preiss J; Schneider DT; Troeger A; Calaminus G; Dilloo D
J Cancer Res Clin Oncol; 2023 Feb; 149(2):791-802. PubMed ID: 35171328
[TBL] [Abstract][Full Text] [Related]
23. Refining the serum miR-371a-3p test for viable germ cell tumor detection: identification and definition of an indeterminate range.
Lafin J; Scarpini C; Amini A; Konneh B; Howard J; Gerald T; Nuno M; Piao J; Savelyeva A; Wang Z; Gagan J; Jia L; Lewis C; Murray S; Sawa Y; Margulis V; Woldu S; Strand D; Coleman N; Amatruda J; Frazier L; Murray M; Bagrodia A
Res Sq; 2023 Mar; ():. PubMed ID: 36993198
[TBL] [Abstract][Full Text] [Related]
24. microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients.
van Agthoven T; Eijkenboom WMH; Looijenga LHJ
Cell Oncol (Dordr); 2017 Aug; 40(4):379-388. PubMed ID: 28612337
[TBL] [Abstract][Full Text] [Related]
25. Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test).
van Agthoven T; Looijenga LHJ
Oncotarget; 2017 Aug; 8(35):58037-58049. PubMed ID: 28938535
[TBL] [Abstract][Full Text] [Related]
26. Serum Level of microRNA-375-3p Is Not a Reliable Biomarker of Teratoma.
Belge G; Grobelny F; Matthies C; Radtke A; Dieckmann KP
In Vivo; 2020; 34(1):163-168. PubMed ID: 31882475
[TBL] [Abstract][Full Text] [Related]
27. MicroRNAs in Differentiation of Embryoid Bodies and the Teratoma Subtype of Testicular Cancer.
Myklebust MP; Søviknes AM; Halvorsen OJ; Thor A; Dahl O; Ræder H
Cancer Genomics Proteomics; 2022; 19(2):178-193. PubMed ID: 35181587
[TBL] [Abstract][Full Text] [Related]
28. The metastatic potential of seminomatous germ cell tumours is associated with a specific microRNA pattern.
Ernst S; Heinzelmann J; Bohle RM; Weber G; Stöckle M; Junker K; Heinzelbecker J
Andrology; 2020 Nov; 8(6):1687-1698. PubMed ID: 32530514
[TBL] [Abstract][Full Text] [Related]
29. A meta-analysis of clinicopathologic features that predict necrosis or fibrosis at post-chemotherapy retroperitoneal lymph node dissection in individuals receiving treatment for non-seminoma germ cell tumours.
Conduit C; Hong W; Martin F; Thomas B; Lawrentschuk N; Goad J; Grimison P; Ahmadi N; Tran B; Lewin J
Front Oncol; 2022; 12():931509. PubMed ID: 36059636
[TBL] [Abstract][Full Text] [Related]
30. Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumors.
Murray MJ; Ajithkumar T; Harris F; Williams RM; Jalloh I; Cross J; Ronghe M; Ward D; Scarpini CG; Nicholson JC; Coleman N
Neurooncol Adv; 2020; 2(1):vdaa048. PubMed ID: 32642701
[TBL] [Abstract][Full Text] [Related]
31. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
Dieckmann KP; Radtke A; Geczi L; Matthies C; Anheuser P; Eckardt U; Sommer J; Zengerling F; Trenti E; Pichler R; Belz H; Zastrow S; Winter A; Melchior S; Hammel J; Kranz J; Bolten M; Krege S; Haben B; Loidl W; Ruf CG; Heinzelbecker J; Heidenreich A; Cremers JF; Oing C; Hermanns T; Fankhauser CD; Gillessen S; Reichegger H; Cathomas R; Pichler M; Hentrich M; Eredics K; Lorch A; Wülfing C; Peine S; Wosniok W; Bokemeyer C; Belge G
J Clin Oncol; 2019 Jun; 37(16):1412-1423. PubMed ID: 30875280
[TBL] [Abstract][Full Text] [Related]
32. CRIPTO and miR-371a-3p Are Serum Biomarkers of Testicular Germ Cell Tumors and Are Detected in Seminal Plasma from Azoospermic Males.
Spiller CM; Lobo J; Boellaard WPA; Gillis AJM; Bowles J; Looijenga LHJ
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32210110
[TBL] [Abstract][Full Text] [Related]
33. Expression of miRNA-371a-3p in seminal plasma and ejaculate is associated with sperm concentration.
Radtke A; Dieckmann KP; Grobelny F; Salzbrunn A; Oing C; Schulze W; Belge G
Andrology; 2019 Jul; 7(4):469-474. PubMed ID: 31310058
[TBL] [Abstract][Full Text] [Related]
34. Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer.
Lobo J; Leão R; Gillis AJM; van den Berg A; Anson-Cartwright L; Atenafu EG; Kuhathaas K; Chung P; Hansen A; Bedard PL; Jewett MAS; Warde P; O'Malley M; Sweet J; Looijenga LHJ; Hamilton RJ
Eur Urol Oncol; 2021 Jun; 4(3):483-491. PubMed ID: 33288479
[TBL] [Abstract][Full Text] [Related]
35. Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p?
Radtke A; Cremers JF; Kliesch S; Riek S; Junker K; Mohamed SA; Anheuser P; Belge G; Dieckmann KP
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2383-2392. PubMed ID: 28819887
[TBL] [Abstract][Full Text] [Related]
36. Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours.
Fankhauser CD; Christiansen AJ; Rothermundt C; Cathomas R; Wettstein MS; Grossmann NC; Grogg JB; Templeton AJ; Hirschi-Blickenstorfer A; Lorch A; Gillessen S; Moch H; Beyer J; Hermanns T
Br J Cancer; 2022 May; 126(8):1140-1144. PubMed ID: 34912073
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA miR-371a-3p - A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele Fluid.
Dieckmann KP; Spiekermann M; Balks T; Ikogho R; Anheuser P; Wosniok W; Loening T; Bullerdiek J; Belge G
Urol Int; 2016; 97(1):76-83. PubMed ID: 26989896
[TBL] [Abstract][Full Text] [Related]
38. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
39. Combining Hypermethylated
Lobo J; van Zogchel LMJ; Nuru MG; Gillis AJM; van der Schoot CE; Tytgat GAM; Looijenga LHJ
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680375
[TBL] [Abstract][Full Text] [Related]
40. Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence.
Christiansen AJ; Lobo J; Fankhauser CD; Rothermundt C; Cathomas R; Batavia AA; Grogg JB; Templeton AJ; Hirschi-Blickenstorfer A; Lorch A; Gillessen S; Moch H; Beyer J; Hermanns T
Front Oncol; 2022; 12():1056823. PubMed ID: 36568207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]